These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15886467)
1. In vitro activity of linezolid against Staphylococcus aureus: a population study. Rodríguez JC; Ethlvarez JM; Escribano I; Royo G Chemotherapy; 2005 May; 51(2-3):86-8. PubMed ID: 15886467 [TBL] [Abstract][Full Text] [Related]
2. [Resistance to linezolid in Staphylococcus aureus before its release]. Akpabie A; Naga H; Giraud K; Al Rahiss R; Nadai S Pathol Biol (Paris); 2004 Oct; 52(8):493-6. PubMed ID: 15465271 [TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus]. Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents. Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Samra Z; Ofer O; Shmuely H Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769 [TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S; Sinirtaş M; Ozakin C Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917 [TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
9. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Johnson AP; Mushtaq S; Warner M; Livermore DM Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254 [TBL] [Abstract][Full Text] [Related]
10. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733 [TBL] [Abstract][Full Text] [Related]
11. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Ross JE; Anderegg TR; Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2005 May; 52(1):53-8. PubMed ID: 15878443 [TBL] [Abstract][Full Text] [Related]
12. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857 [No Abstract] [Full Text] [Related]
13. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL; Kiffer CR; Mendes CM; Nicolau DP Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus. Hannan A; Absar M; Usman M; Naeem T; Saleem S; Arshad M J Ayub Med Coll Abbottabad; 2009; 21(1):106-9. PubMed ID: 20364755 [TBL] [Abstract][Full Text] [Related]
15. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476 [TBL] [Abstract][Full Text] [Related]
16. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA). Leonard SN; Szeto YG; Zolotarev M; Grigoryan IV Int J Antimicrob Agents; 2011 Jun; 37(6):558-61. PubMed ID: 21497067 [TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates. Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains. Kaya O; Akcam FZ; Temel EN Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600 [TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]